1. Home
  2. NMRA vs MCFT Comparison

NMRA vs MCFT Comparison

Compare NMRA & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NMRA
  • MCFT
  • Stock Information
  • Founded
  • NMRA 2019
  • MCFT 1968
  • Country
  • NMRA United States
  • MCFT United States
  • Employees
  • NMRA N/A
  • MCFT N/A
  • Industry
  • NMRA
  • MCFT Marine Transportation
  • Sector
  • NMRA
  • MCFT Industrials
  • Exchange
  • NMRA Nasdaq
  • MCFT Nasdaq
  • Market Cap
  • NMRA 287.6M
  • MCFT 286.5M
  • IPO Year
  • NMRA 2023
  • MCFT 2015
  • Fundamental
  • Price
  • NMRA $1.13
  • MCFT $17.30
  • Analyst Decision
  • NMRA Buy
  • MCFT Buy
  • Analyst Count
  • NMRA 8
  • MCFT 4
  • Target Price
  • NMRA $10.14
  • MCFT $20.50
  • AVG Volume (30 Days)
  • NMRA 1.3M
  • MCFT 73.3K
  • Earning Date
  • NMRA 03-03-2025
  • MCFT 05-07-2025
  • Dividend Yield
  • NMRA N/A
  • MCFT N/A
  • EPS Growth
  • NMRA N/A
  • MCFT N/A
  • EPS
  • NMRA N/A
  • MCFT N/A
  • Revenue
  • NMRA N/A
  • MCFT $311,260,000.00
  • Revenue This Year
  • NMRA N/A
  • MCFT N/A
  • Revenue Next Year
  • NMRA N/A
  • MCFT $20.29
  • P/E Ratio
  • NMRA N/A
  • MCFT N/A
  • Revenue Growth
  • NMRA N/A
  • MCFT N/A
  • 52 Week Low
  • NMRA $1.13
  • MCFT $16.12
  • 52 Week High
  • NMRA $17.19
  • MCFT $24.05
  • Technical
  • Relative Strength Index (RSI)
  • NMRA 26.07
  • MCFT 43.00
  • Support Level
  • NMRA $1.13
  • MCFT $17.03
  • Resistance Level
  • NMRA $1.23
  • MCFT $17.67
  • Average True Range (ATR)
  • NMRA 0.12
  • MCFT 0.62
  • MACD
  • NMRA 0.05
  • MCFT 0.02
  • Stochastic Oscillator
  • NMRA 3.54
  • MCFT 43.34

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has rapidly scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. The company expects to continue to progress in the development of its pipeline with the planned initiation of multiple clinical trials across its programs over the next 12 to 18 months, which supports numerous anticipated data readouts.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: